...
首页> 外文期刊>International Journal of Food Science >Use of α -Lactalbumin and Caseinoglycomacropeptide as Biopeptide Precursors and as Functional Additives in Milk Beverages Fermented by L. helveticus
【24h】

Use of α -Lactalbumin and Caseinoglycomacropeptide as Biopeptide Precursors and as Functional Additives in Milk Beverages Fermented by L. helveticus

机译:使用α-乳腺蛋白和酪蛋白杂交肽作为生物肽前体,并作为L. helveticus发酵的牛奶饮料中的功能添加剂

获取原文
           

摘要

The objective of this investigation was to verify whether biologically active peptides (BAPs) could be obtained from water solutions of α -lactalbumin ( α -la) and caseinoglycomacropeptide (CGMP) through an application of the new Lactobacillus helveticus strains. Also, the aim of this research was to determine the influence of addition of the analyzed protein preparations to milk subjected to fermentation by tested bacterial strains on the physicochemical properties of obtained milk beverages. The results indicate that CGMP is a more preferable source for the production of BAPs by the test bacteria than α -la. The antihypertensive and ACE inhibitory effects were the most widespread bioactivities among the detected BAPs. α -la containing fermented milk beverages had higher values of springiness, gumminess, chewiness, and resilience than analogous products containing CGMP, while CGMP-supplemented fermented products exhibited higher values of the hardness parameter. The highest values of hardness ( ?N) were recorded for beverages fermented by DSMZ containing the addition of CGMP, while the lowest value of this parameter ( ?N) was noted for products containing α -la and fermented by B734. Moreover, CGMP-containing fermented products were characterized by a generally higher value of the proteolysis index (PI) than analogous variants containing α -la. The use of analyzed strains and the selected protein preparations has a positive effect on the texture of fermented milk beverages and might contribute to an increase in the health-promoting potential of such products.
机译:该研究的目的是通过应用新的乳杆菌Helveticus菌株来验证生物活性肽(BAPS)是否可以从α-乳酰胺(α-LA)和酪蛋白蛋白酶(CGMP)的水溶液中获得。此外,该研究的目的是确定通过测试的细菌菌株对经过所得乳饮料的物理化学性质进行经过测试的细菌菌株进行发酵的分析蛋白制剂的影响。结果表明,CGMP是一种比α-1A的试验细菌生产的更优选的源。抗高血压和ACE抑制作用是检测到的容器中最普遍的生物活性。含有发酵乳饮料的α-1A的弹性值较高,比含有CGMP的类似产品的弹性,荧光,咀嚼性和弹性,而CGMP补充发酵产物表现出较高的硬度参数值。记录了含有CGMP的DSMZ发酵的饮料的饮料的最高值,而含有α-1A的产物并由B734发酵的产品,则注意到该参数(αn)的最低值。此外,含CGMP的发酵产物的特征在于蛋白水解指数(PI)的通常比含有α-1A的类似变体的较高值。使用分析的菌株和所选蛋白质制剂对发酵乳饮料的质地具有积极影响,并且可能导致这些产品的健康促进潜力的增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号